Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis

Yasuo Yoshihara, Harumoto Yamada

研究成果: Review article

10 引用 (Scopus)

抄録

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.

元の言語English
ページ(範囲)500-508
ページ数9
ジャーナルClinical calcium
17
発行部数4
出版物ステータスPublished - 04-2007

Fingerprint

Matrix Metalloproteinases
Cartilage
Rheumatoid Arthritis
Aggrecans
Synovial Fluid
Articular Cartilage
Extracellular Matrix
Peptide Hydrolases
Collagen
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

@article{a5354876b92b4ce6b553cf30c0344551,
title = "Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis",
abstract = "Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.",
author = "Yasuo Yoshihara and Harumoto Yamada",
year = "2007",
month = "4",
language = "English",
volume = "17",
pages = "500--508",
journal = "Clinical calcium",
issn = "0917-5857",
publisher = "Iyaku (Medicine & Drug) Journal Co",
number = "4",

}

Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. / Yoshihara, Yasuo; Yamada, Harumoto.

:: Clinical calcium, 巻 17, 番号 4, 04.2007, p. 500-508.

研究成果: Review article

TY - JOUR

T1 - Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis

AU - Yoshihara, Yasuo

AU - Yamada, Harumoto

PY - 2007/4

Y1 - 2007/4

N2 - Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.

AB - Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.

UR - http://www.scopus.com/inward/record.url?scp=34250182412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250182412&partnerID=8YFLogxK

M3 - Review article

C2 - 17404478

AN - SCOPUS:34250182412

VL - 17

SP - 500

EP - 508

JO - Clinical calcium

JF - Clinical calcium

SN - 0917-5857

IS - 4

ER -